Seeing Is Believing
Currently out of the existing stock ratings of Glen Santangelo, 103 are a BUY (66.45%), 50 are a HOLD (32.26%), 2 are a SELL (1.29%).
Analyst Glen Santangelo, currently employed at JEFFERIES, carries an average stock price target met ratio of 62.16% that have a potential upside of 28.4% achieved within 203 days.
Glen Santangelo’s has documented 326 price targets and ratings displayed on 40 stocks. The coverage is on Healthcare, Consumer Defensive, Technology sectors.
Most recent stock forecast was given on HQY, HealthEquity at 03-Sep-2025.
Analyst best performing recommendations are on ALGN (ALIGN TECHNOLOGY).
The best stock recommendation documented was for ALGN (ALIGN TECHNOLOGY) at 10/7/2019. The price target of $200 was fulfilled within 4 days with a profit of $15.49 (8.4%) receiving and performance score of 20.99.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$215
$40.04 (22.89%)
$187
2 years 1 months 7 days ago
(07-Aug-2023)
13/14 (92.86%)
$28.91 (15.54%)
633
Hold
$190
$15.04 (8.60%)
$176
2 years 1 months 11 days ago
(03-Aug-2023)
8/8 (100%)
$-0.86 (-0.45%)
433
Buy
$220
$45.04 (25.74%)
$213
2 years 1 months 11 days ago
(03-Aug-2023)
11/17 (64.71%)
$29.14 (15.27%)
326
Buy
$215
$40.04 (22.89%)
$200
2 years 1 months 11 days ago
(03-Aug-2023)
6/8 (75%)
$24.14 (12.65%)
220
Buy
$225
$50.04 (28.60%)
$184
2 years 1 months 13 days ago
(01-Aug-2023)
11/12 (91.67%)
$36.39 (19.29%)
557
Which stock is Glen Santangelo is most bullish on?
Which stock is Glen Santangelo is most reserved on?
What Year was the first public recommendation made by Glen Santangelo?